GB1415295A - Substituted phenoxy-alkyl-carboxylic acids and derivatives thereof - Google Patents
Substituted phenoxy-alkyl-carboxylic acids and derivatives thereofInfo
- Publication number
- GB1415295A GB1415295A GB4792771A GB4792771A GB1415295A GB 1415295 A GB1415295 A GB 1415295A GB 4792771 A GB4792771 A GB 4792771A GB 4792771 A GB4792771 A GB 4792771A GB 1415295 A GB1415295 A GB 1415295A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- halo
- alkoxy
- agents
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 abstract 2
- GRDGBWVSVMLKBV-UHFFFAOYSA-N (2-amino-5-nitrophenyl)-(2-chlorophenyl)methanone Chemical compound NC1=CC=C([N+]([O-])=O)C=C1C(=O)C1=CC=CC=C1Cl GRDGBWVSVMLKBV-UHFFFAOYSA-N 0.000 abstract 1
- YGWOQHVFLNTQNZ-UHFFFAOYSA-N 4-(2-ethoxy-2-oxoethoxy)benzoic acid Chemical compound CCOC(=O)COC1=CC=C(C(O)=O)C=C1 YGWOQHVFLNTQNZ-UHFFFAOYSA-N 0.000 abstract 1
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 abstract 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 abstract 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 abstract 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000003434 antitussive agent Substances 0.000 abstract 1
- 229940124584 antitussives Drugs 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 239000002327 cardiovascular agent Substances 0.000 abstract 1
- 229940125692 cardiovascular agent Drugs 0.000 abstract 1
- 238000001311 chemical methods and process Methods 0.000 abstract 1
- 125000004465 cycloalkenyloxy group Chemical group 0.000 abstract 1
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 239000004089 psychotropic agent Substances 0.000 abstract 1
- IMCGHZIGRANKHV-AJNGGQMLSA-N tert-butyl (3s,5s)-2-oxo-5-[(2s,4s)-5-oxo-4-propan-2-yloxolan-2-yl]-3-propan-2-ylpyrrolidine-1-carboxylate Chemical compound O1C(=O)[C@H](C(C)C)C[C@H]1[C@H]1N(C(=O)OC(C)(C)C)C(=O)[C@H](C(C)C)C1 IMCGHZIGRANKHV-AJNGGQMLSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/24—Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/373—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in doubly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2003430A DE2003430C3 (de) | 1969-01-31 | 1970-01-27 | p-Benzoylphenoxyisobuttersäureester, ihre Herstellung und diese enthaltende Arzneimittel |
GB4792771A GB1415295A (en) | 1971-10-14 | 1971-10-14 | Substituted phenoxy-alkyl-carboxylic acids and derivatives thereof |
FR7236165A FR2157853B2 (enrdf_load_stackoverflow) | 1971-10-14 | 1972-10-12 | |
DE2250327A DE2250327C2 (de) | 1969-01-31 | 1972-10-13 | Phenoxyibuttersäurederivate, ihre Säureadditionssalze, Verfahren zu deren Herstellung und pharmazeutische Mittel |
BE790026D BE790026R (fr) | 1969-01-31 | 1972-10-13 | Procede de preparation de corps derives de l'acide |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4792671 | 1971-10-14 | ||
GB4792771A GB1415295A (en) | 1971-10-14 | 1971-10-14 | Substituted phenoxy-alkyl-carboxylic acids and derivatives thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1415295A true GB1415295A (en) | 1975-11-26 |
Family
ID=26266167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4792771A Expired GB1415295A (en) | 1969-01-31 | 1971-10-14 | Substituted phenoxy-alkyl-carboxylic acids and derivatives thereof |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2157853B2 (enrdf_load_stackoverflow) |
GB (1) | GB1415295A (enrdf_load_stackoverflow) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4242358A (en) * | 1979-01-24 | 1980-12-30 | Societe De Recherches Industrielles (Sori) | Method of treatment of algiae |
US4661505A (en) * | 1982-11-03 | 1987-04-28 | Eli Lilly And Company | Leukotriene antagonists |
US4801616A (en) * | 1986-03-25 | 1989-01-31 | Eli Lilly And Company | Diphenylmethanone compounds and anti-inflammatory use thereof |
US4853404A (en) * | 1986-10-13 | 1989-08-01 | Tanabe Seiyaku Co., Ltd. | Phenoxyacetic acid derivatives composition and use |
US6013839A (en) * | 1996-02-15 | 2000-01-11 | Rhone-Poulenc Agriculture Limited | Process for preparing 2-(thiosubstituted)-4-haloacetophenones |
US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
US7030106B2 (en) | 2001-01-26 | 2006-04-18 | Schering Corporation | Sterol absorption inhibitor compositions |
US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
US7132415B2 (en) | 2001-09-21 | 2006-11-07 | Schering Corporation | Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors |
US7192944B2 (en) | 2003-03-07 | 2007-03-20 | Schering Corp. | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
WO2006135480A3 (en) * | 2005-04-08 | 2007-04-05 | Abbott Lab | Oral pharmaceutical formulations comprising fenofibric acid and/or its salts |
US7208486B2 (en) | 2003-03-07 | 2007-04-24 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7235543B2 (en) | 2003-03-07 | 2007-06-26 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7417039B2 (en) | 2001-01-26 | 2008-08-26 | Schering Corporation | Use of substituted azetidinone compounds for the treatment of sitosterolemia |
US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7560449B2 (en) | 2002-11-06 | 2009-07-14 | Schering Corporation | Methods and therapeutic combinations for the treatment of demyelination |
US20100185008A1 (en) * | 2007-07-05 | 2010-07-22 | Finorga | Method for Producing Fenofibrate |
WO2012055014A1 (en) | 2010-10-27 | 2012-05-03 | Prometic Biosciences Inc. | Phenylketone carboxylate compounds and pharmaceutical uses thereof |
CN107261149A (zh) * | 2008-12-04 | 2017-10-20 | 于崇曦 | 高穿透性组合物及其应用 |
WO2021019493A1 (en) | 2019-07-31 | 2021-02-04 | Intas Pharmaceuticals Ltd. | Pharmaceutical composition comprising hmg-coa reductase inhibitors and fenofibrate |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1517603A (en) * | 1976-04-02 | 1978-07-12 | Lafon Labor | Esters of 2-(4-(4-chlorobenzoyl)-phenoxy)-2-methyl-propionic acid with bis-(hydroxyalkylthio)-alkanes |
GB1520602A (en) * | 1976-04-02 | 1978-08-09 | Lafon Labor | Esters of bis-(hydroxyalkylthio)-alkanes |
GB2025942A (en) * | 1978-05-31 | 1980-01-30 | Sori Soc Rech Ind | Phenoxyalkylcarboxylic acids |
FR2494112B1 (enrdf_load_stackoverflow) * | 1980-11-19 | 1986-01-10 | Laruelle Claude | |
FR2886844B1 (fr) * | 2005-06-09 | 2007-09-14 | Oreal | Utilisation de composes 2-oxy-acetamide pour favoriser et/ou induire et/ou stimuler la pigmentation des matieres keratiniques et/ou limiter leur depigmentation et/ou leur blanchiment |
FR2918367A1 (fr) * | 2007-07-05 | 2009-01-09 | Finorga Soc Par Actions Simpli | Procede de preparation du fenofibrate |
FR2918662B1 (fr) * | 2007-07-10 | 2009-10-30 | Finorga Soc Par Actions Simpli | Procede de preparation du fenofibrate |
MX2022015336A (es) | 2020-09-29 | 2023-01-11 | Laboratorios Silanes S A De C V | Combinaciones farmaceuticas de estatinas y fibratos para el tratamiento y prevencion de hiperlipidemias y enfermedades cardiovasculares. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3379755A (en) * | 1964-06-04 | 1968-04-23 | Merck & Co Inc | Preparation of (4-alkanoylphenoxy) acetic acids by oxidation |
FR4963M (enrdf_load_stackoverflow) * | 1965-09-15 | 1967-05-08 | ||
CH528101A (de) * | 1970-03-11 | 1972-09-15 | Ciba Geigy Ag | Verwendung von 2-Hydroxybenzophenonen als Stabilisierungsmittel gegen Ultraviolettstrahlung in farbphotographischem Material |
-
1971
- 1971-10-14 GB GB4792771A patent/GB1415295A/en not_active Expired
-
1972
- 1972-10-12 FR FR7236165A patent/FR2157853B2/fr not_active Expired
Cited By (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4242358A (en) * | 1979-01-24 | 1980-12-30 | Societe De Recherches Industrielles (Sori) | Method of treatment of algiae |
US4661505A (en) * | 1982-11-03 | 1987-04-28 | Eli Lilly And Company | Leukotriene antagonists |
US4801616A (en) * | 1986-03-25 | 1989-01-31 | Eli Lilly And Company | Diphenylmethanone compounds and anti-inflammatory use thereof |
US4853404A (en) * | 1986-10-13 | 1989-08-01 | Tanabe Seiyaku Co., Ltd. | Phenoxyacetic acid derivatives composition and use |
US6013839A (en) * | 1996-02-15 | 2000-01-11 | Rhone-Poulenc Agriculture Limited | Process for preparing 2-(thiosubstituted)-4-haloacetophenones |
US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
US7030106B2 (en) | 2001-01-26 | 2006-04-18 | Schering Corporation | Sterol absorption inhibitor compositions |
US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
US7612058B2 (en) | 2001-01-26 | 2009-11-03 | Schering Corporation | Methods for inhibiting sterol absorption |
US7417039B2 (en) | 2001-01-26 | 2008-08-26 | Schering Corporation | Use of substituted azetidinone compounds for the treatment of sitosterolemia |
US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
US7132415B2 (en) | 2001-09-21 | 2006-11-07 | Schering Corporation | Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors |
US7560449B2 (en) | 2002-11-06 | 2009-07-14 | Schering Corporation | Methods and therapeutic combinations for the treatment of demyelination |
US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7732413B2 (en) | 2003-03-07 | 2010-06-08 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7368563B2 (en) | 2003-03-07 | 2008-05-06 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7368562B2 (en) | 2003-03-07 | 2008-05-06 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7378518B2 (en) | 2003-03-07 | 2008-05-27 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7235543B2 (en) | 2003-03-07 | 2007-06-26 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7208486B2 (en) | 2003-03-07 | 2007-04-24 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7741289B2 (en) | 2003-03-07 | 2010-06-22 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7192944B2 (en) | 2003-03-07 | 2007-03-20 | Schering Corp. | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
EA023376B1 (ru) * | 2005-04-08 | 2016-05-31 | Эббот Лабораториз | Твердая дозированная форма и содержащая ее упаковка для комбинированной терапии |
NO20075628L (no) * | 2005-04-08 | 2007-11-05 | Bgp Products Ireland Ltd | Farmasøytiske formuleringer |
WO2006135480A3 (en) * | 2005-04-08 | 2007-04-05 | Abbott Lab | Oral pharmaceutical formulations comprising fenofibric acid and/or its salts |
NO343548B1 (no) * | 2005-04-08 | 2019-04-01 | Bgp Products Ireland Ltd | Farmasøytiske formuleringer |
US20100185008A1 (en) * | 2007-07-05 | 2010-07-22 | Finorga | Method for Producing Fenofibrate |
CN111808011A (zh) * | 2008-12-04 | 2020-10-23 | 于崇曦 | 高穿透性组合物及其应用 |
CN108191846B (zh) * | 2008-12-04 | 2021-08-20 | 于崇曦 | 高穿透性组合物及其应用 |
CN111808011B (zh) * | 2008-12-04 | 2024-02-27 | 泰飞尔生物医药(苏州)有限公司 | 高穿透性组合物及其应用 |
US11541029B2 (en) | 2008-12-04 | 2023-01-03 | Techfields Pharma Co., Ltd. | High penetration compositions and their applications |
CN107261149A (zh) * | 2008-12-04 | 2017-10-20 | 于崇曦 | 高穿透性组合物及其应用 |
CN108191846A (zh) * | 2008-12-04 | 2018-06-22 | 于崇曦 | 高穿透性组合物及其应用 |
CN113636965A (zh) * | 2008-12-04 | 2021-11-12 | 于崇曦 | 高穿透性组合物及其应用 |
KR20130140745A (ko) * | 2010-10-27 | 2013-12-24 | 프로메틱 바이오사이언시즈 인코포레이티드 | 페닐케톤 카복실레이트 화합물 및 그의 약제학적 용도 |
WO2012055014A1 (en) | 2010-10-27 | 2012-05-03 | Prometic Biosciences Inc. | Phenylketone carboxylate compounds and pharmaceutical uses thereof |
EA022988B1 (ru) * | 2010-10-27 | 2016-04-29 | Прометик Биосайнсиз Инк. | Соединения фенилкетонкарбоксилата и их фармацевтическое применение |
KR101870468B1 (ko) | 2010-10-27 | 2018-06-22 | 프로메틱 파마 에스엠티 리미티드 | 페닐케톤 카복실레이트 화합물 및 그의 약학 용도 |
US9475750B2 (en) | 2010-10-27 | 2016-10-25 | Prometic Biosciences Inc. | Phenylketone carboxylate compounds and pharmaceutical uses thereof |
EA022988B9 (ru) * | 2010-10-27 | 2016-08-31 | Прометик Биосайнсиз Инк. | Соединения фенилкетонкарбоксилата и их фармацевтическое применение |
WO2021019493A1 (en) | 2019-07-31 | 2021-02-04 | Intas Pharmaceuticals Ltd. | Pharmaceutical composition comprising hmg-coa reductase inhibitors and fenofibrate |
EP4115879A1 (en) | 2019-07-31 | 2023-01-11 | Intas Pharmaceuticals Ltd. | Pharmaceutical composition comprising hmg-coa reductase inhibitors and fenofibrate |
Also Published As
Publication number | Publication date |
---|---|
FR2157853A2 (enrdf_load_stackoverflow) | 1973-06-08 |
FR2157853B2 (enrdf_load_stackoverflow) | 1975-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1415295A (en) | Substituted phenoxy-alkyl-carboxylic acids and derivatives thereof | |
AU557691B2 (en) | 2-penem antibiotics and their oxa-aza-, and carba analogues | |
ES527954A1 (es) | Un procedimiento para preparar isoxazoles | |
DE3279103D1 (en) | New cephem compounds, processes for preparation thereof and pharmaceutical composition containing them | |
GB1496579A (en) | Cyano-pyridine derivatives | |
FI73969B (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva trans-4-aminometylcyklohexankarboxylsyraderivat. | |
ES465157A1 (es) | Un procedimiento para la preparacion de un acido hidroxami- co. | |
GB1507032A (en) | 2-thiol-4,5-diphenyloxazole s-derivatives | |
JPS5543077A (en) | Preparation of 1,3-dithiolan-2-ylidenemalonate derivative | |
JPS5283396A (en) | Novel compound physiologically acceptable salts thereof process for preparing same and medical composition containing same | |
GB1493684A (en) | S-substituted-2-thiodenosines | |
ES376688A1 (es) | Procedimiento para la produccion de una 3h-1,4-benzodiacepi-ra. | |
ES8307780A1 (es) | "procedimiento para la preparacion de acidos fenilalcohiloxirancarboxilicos". | |
ATE18993T1 (de) | Dibenzocycloheptenyliden-verbindungen zur verwendung bei der modulation der immunreaktion. | |
GB1369578A (en) | Pharmaceutical compositions containing indole-caboxylic acid derivatives | |
WO1987004435A3 (en) | Xanthine compounds | |
GB1368470A (en) | Antiviral compositions containing bisbasic ketones of dibenzofu ran and methods of treating viruses therewith | |
ES528460A0 (es) | Procedimiento de preparacion de nuevos deridados de alfa-etibenzol con un grupo amino propanolico sustituido y sus sales de adicion acidas y amonicas cuaternarias. | |
ES417065A1 (es) | Procedimiento para la preparacion de nuevos derivados de n-(triaril-metil)-amidina. | |
GB1501588A (en) | 4,5-disubstituted 2-oxazolealkanoic acids esters and alkali metal salts | |
GB1297206A (enrdf_load_stackoverflow) | ||
GB1472487A (en) | Benzodiazepine derivatives | |
JPS527919A (en) | Process for preparation of beta-sulfenylacrylic acid and its salt | |
JPS56142260A (en) | 2-azetidinone and its preparation | |
GB1369770A (en) | 1-methyl-3-alkoxymethyl-5,5,-disubstituted barbituric acid compounds and therapeutic compositions containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PE20 | Patent expired after termination of 20 years |